This story originally ran on Feb. 23.

Harvard University has granted the exclusive rights to certain diagnostic technologies to a not-for-profit firm founded to make lab-on-a-chip tests available to developing nations at low cost or for free.

The agreement gives the company, Diagnostics For All, the rights to microfluidic technologies developed in the laboratory of George Whitesides, a professor of chemistry at Harvard and co-founder of DFA.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.